Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Blueprint Medicines Corp banner
B

Blueprint Medicines Corp
F:2L9

Watchlist Manager
Blueprint Medicines Corp
F:2L9
Watchlist
Price: 110.05 EUR
Market Cap: €6.9B
Write Note Create Alert Ask AI

DCF Value

The DCF Value for Blueprint Medicines Corp (2L9) under the Base Case is hidden EUR. Compared with the current market price of 110.05 EUR, the stock appears hidden .

Key assumptions
2L9 DCF Value
LOCKED
Unlock

DCF Model

DCF Assumptions
Revenue Growth 11.9%
Operating Margin 10.4%22.9%
Cash Flow Conversion 71%
Forecast Period 10 years
Model Settings
Template via FCFF
Discount Rate 9.5%
Exit Multiple 6.2x EV/REVENUE
Valuation Result
·
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time

Continue 2L9 Research

Summary
2L9 intrinsic value, competitors valuation, and company profile.
DCF Valuation
2L9 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
2L9 stock valuation using valuation multiples.
Wall St Estimates
2L9 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
2L9 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
ALPHA SPREAD
Follow us
Join 361,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.